You are viewing a free limited preview of BioVectra Inc.
Get Full Access To This Report 
| or | Upgrade to PrivCo Premium |
| $99 Single Company Access | Instant Full Site-Wide Access Currently 50% Off Until May. 31! |
BioVectra Inc. is a privately-held supplier of chemicals to the pharmaceutical and biotechnology industry. BioVectra Inc. headquarters are located in Charlottetown, Prince Edward Island, Canada.
| Company Tags: | VC Backed |
| Year Founded: | 1970 |
| Formerly Named: | BioVectra DCL Diagnostic Chemicals Limited |
| Fiscal Year End: | 08/31 |
| 1YR Revenue Growth Rate: | View % |
| 3YR Revenue Growth Rate (CAGR): | View % |
| 1YR Employee Growth Rate: | View % |
| 3YR Employee Growth Rate (CAGR): | View % |
| City: | Charlottetown |
| State/Province: | Prince Edward Island |
| Country: | Canada |
| Website: | www.biovectra.com |
The PrivCo Industry Classification System™ (PICS) is our proprietary, modernized industry classification system, geared especially toward privately-held companies and including newer emerging sub-industries that are not reflected in other outdated industry classification systems, such as SIC and NAICS.
Export All BioVectra Inc. Financials To Excel
$99 Single Company AccessInstant Full Site-Wide Access| Income Statement | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 |
| Revenues | View | View | View | View | View | View |
| Balance Sheet | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 |
| Current Assets | View | View | View | View | View | |
| Non-Current Assets | View | View | View | View | View | |
| Total Assets | View | View | View | View | View | View |
| Current Liabilities | View | View | View | View | View | |
| Employee Figures | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 |
| Total Employees | View | View | View | View | View | View |
| Productivity (Revenue/Employee) | View | View | View | View | View | View |
| Financial Notes: | |
| * | BioVectra Inc. fiscal year end: 08/31 |
Export All BioVectra Inc. Financials To Excel
$99 Single Company AccessInstant Full Site-Wide AccessBioVectra Inc. Revenues (C$ MM, CAD): |
BioVectra Inc. Current Assets ($ MM): |
BioVectra Inc. Non-Current Assets ($ MM): |
BioVectra Inc. Total Assets (C$ MM, CAD): |
BioVectra Inc. Current Liabilities ($ MM): |
BioVectra Inc. Total Employees: |
BioVectra Inc. Productivity (Revenue/Employee) (C$, CAD): |
Export Financials to Excel
$99 Single Company AccessInstant Full Site-Wide Access| Date | Status | Target | Buyer | Deal Type | Price | |
| Details | Oct. 2009 | Completed | View1 | View | Minority Stake Purchase | View |
| 1 | BioVectra, Inc., a cGMP manufacturing...Read More → |
Full-length notes are available with Single Report Access or PrivCo Premium Subscription. |
Missing a deal? Tell us about it! tips@privco.com
$99 Single Company AccessInstant Full Site-Wide Access| Date | Investor | Round | Investor Type | |
| Jan. 2008 | View | Grant | Quasi-Government Organization | |
| Details | Total Round Grant View | |||
| Aug. 2010 | View | Debt Funding | Quasi-Government Organization | |
| Details | Total Round Debt Funding View | |||
| Total of Funding Shown Above View | ||||
| 1 | BioVectra received $3MM in funding...Read More → |
| 2 | The low-interest loan was provided...Read More → |
Full-length notes are available with Single Report Access or PrivCo Premium Subscription. |
Missing a deal? Tell us about it! tips@privco.com
$99 Single Company AccessInstant Full Site-Wide AccessDiagnostic Chemicals Limited initiated research and development operations in 1970 as a home-based business that manufactured small amounts of iodonitrotetrazolium chloride, a specialty chemical also known as INT dye. Since, Diagnostic Chemicals Ltd. has substantially increased its product line and capabilities, becoming one of the largest producers of chemical reagents and analytical kits in the world. The company focuses product development on providing protein engineering tools and transformation systems that offer commercial solutions to its customers while developing and manufacturing specialty and fine chemicals, advanced intermediates, enzymes, and biomolecules. In 2007, BioVectra DCL becomes incorporated and begins operating under BioVectra Inc. due to the sale of DCL’s diagnostic division of Genzyme Corporation. The company operates three FDA-inspected facilities. Headquartered in Prince Edward Island, Canada, BioVectra’s facilities are equipped to provide… Continue Reading →
$99 Single Company AccessInstant Full Site-Wide Access|
Get Full Access To This Report
| or | Upgrade to PrivCo Premium |
| $99 Single Company Access | Instant Full Site-Wide Access Currently 50% Off Until May. 31! |
PrivCo is the authority for financial & business data on major private companies, including:
| Private Companies | 209,371 |
| Private Investors | 12,087 |
| Private M&A Deals | 43,291 |
| VC/Funding Rounds | 36,227 |
| Total Data Points | 95,786,176 |
You are viewing a free limited preview of BioVectra Inc.
PrivCo is the premier source for business and financial data on major, non-publicly traded corporations, including family owned, private equity owned, venture backed, and international unlisted companies. Click here to learn more.
PDF VERSION: Download Company Report in PDF Format
Full Online Report
